欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
LV/H/0118/001
药品名称
Ezaprev
活性成分
pramipexole 0.09 mg
剂型
Tablet
上市许可持有人
UAB Norameda Meistru 8a, Vilnius LT-02189, Lithuania
参考成员国 - 产品名称
Latvia (LV)
Ezaprev 0.088 mg tablets
互认成员国 - 产品名称
Lithuania (LT)
Ezaprev 0,088mg tabletės
许可日期
2009/03/12
最近更新日期
2023/03/17
药物ATC编码
N04BC05 pramipexole
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
LV_H_0118_001_003_IB_007_PIL_ENG clean
Date of last change:2024/09/06
Final SPC
|
LV_H_0118_001_003_IB_007_SmPC_ENG clean
Date of last change:2024/09/06
Final Labelling
|
LV_H_0118_001_IB_006_labelling_clean
Date of last change:2024/09/06
Final Labelling
|
LV_H_0118_002_IB_006_labelling_clean
Date of last change:2024/09/06
Final Labelling
|
LV_H_0118_003_IB_006_labelling_clean
Date of last change:2024/09/06
PubAR
|
parmod5_dk1415ezaprev_pdf
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase